{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:47:36Z","timestamp":1762458456828},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T00:00:00Z","timestamp":1124409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00198-005-1998-x","type":"journal-article","created":{"date-parts":[[2005,8,18]],"date-time":"2005-08-18T16:44:22Z","timestamp":1124383462000},"page":"2080-2084","source":"Crossref","is-referenced-by-count":14,"title":["Changes in serum fibroblast growth factor\u00a02 in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1\u201334)"],"prefix":"10.1007","volume":"16","author":[{"given":"Marja","family":"Hurley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,8,19]]},"reference":[{"key":"1998_CR1","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"1998_CR2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","volume":"349","author":"Black","year":"2003","unstructured":"Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lane TL, Garnero P, Bouxsein ML, Biliezikian J, Rosen CJ (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207\u20131215","journal-title":"N Engl J Med"},{"key":"1998_CR3","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","volume":"349","author":"Finkelstein","year":"2003","unstructured":"Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349:1216\u20131226","journal-title":"N Engl J Med"},{"key":"1998_CR4","doi-asserted-by":"crossref","unstructured":"Hurley MM, Marie P, Florkiewicz R (2002) Fibroblast growth factor and fibroblast growth factor receptor families in bone. In: Bilezikian JP, Raisz LG, Rodan G (eds) Principles of bone biology. Academic, San Diego, pp 825\u2013851","DOI":"10.1016\/B978-012098652-1\/50149-9"},{"key":"1998_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/08977199308991583","volume":"9","author":"Mayahara","year":"1993","unstructured":"Mayahara H, Ito T, Nagai H, Miyajima H, Tsukuda R, Takatomi S, Mizoguchi J, Kato K (1993) In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9:73\u201380","journal-title":"Growth Factors"},{"key":"1998_CR6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1359\/jbmr.1999.14.5.776","volume":"14","author":"Hurley","year":"1999","unstructured":"Hurley MM, Tetradis S, Huang YF, Hock J, Kream BE, Raisz LG Sabbieti MG (1999) Parathyroid hormone regulates the expression of fibroblast growth factor\u00a02 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J Bone Miner Res 14:776\u2013783","journal-title":"J Bone Miner Res"},{"key":"1998_CR7","doi-asserted-by":"crossref","first-page":"21258","DOI":"10.1074\/jbc.M302113200","volume":"278","author":"Okada","year":"2003","unstructured":"Okada Y, Montero A, Zhang X, Sobue T, Lorenzo J, Doetschman T, Coffin JD, Hurley MM (2003) Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone. J Biol Chem 278:21258\u201321266","journal-title":"J Biol Chem"},{"key":"1998_CR8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI3914","volume":"102","author":"Lane","year":"1998","unstructured":"Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD (1998) Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 102:1627\u20131633","journal-title":"J Clin Invest"},{"key":"1998_CR9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s001980070111","volume":"11","author":"Lane","year":"2000","unstructured":"Lane NE, Sanchez S, Genant HK, Jenkins DK, Arnaud CD (2000) Short term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis. Osteoporos Int 11:434\u2013442","journal-title":"Osteoporos Int"},{"key":"1998_CR10","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2003-032066","volume":"89","author":"Buxton","year":"2004","unstructured":"Buxton EC, Yao W, Lane NE (2004) Changes in serum receptor activator of nuclear factor-kappa\u00a0B ligand, osteoprotegerin, and interleukin\u00a06 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1\u201334). J Clin Endocrinol Metab 89:3332\u20133336","journal-title":"J Clin Endocrinol Metab"},{"key":"1998_CR11","unstructured":"Canalis E, Hock JM, Raisz LG (1994) Anabolic and catabolic effects of parathyroid hormone on bone and interactions with growth factors. The parathyroids, Chap\u00a04, pp 65\u201382"},{"key":"1998_CR12","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1210\/endo.142.10.8436","volume":"142","author":"Miyakoshi","year":"2001","unstructured":"Miyakoshi N, Kasukawa Y, Linkart T, Baylink DJ, Mohan S (2001) Evidence that the anabolic effect of PTH on bone require IGF\u00a01 in growing mice. Endocrinology 142:4349\u20134356","journal-title":"Endocrinology"},{"key":"1998_CR13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1006\/bbrc.2001.6217","volume":"290","author":"Zhang","year":"2002","unstructured":"Zhang X, Sobue T, Hurley MM (2002) FGF-2 increases colony formation, PTH receptor, and IGF-1 mRNA in mouse marrow stromal cell cultures. Biochem Biophys Res Commun 290:526\u2013531","journal-title":"Biochem Biophys Res Commun"},{"key":"1998_CR14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S8756-3282(02)00799-8","volume":"31","author":"Power","year":"2002","unstructured":"Power RA, Iwanec UT, Wronski TJ (2002) Changes in gene expression associated with the bone anabolic effects of basic fibroblast growth factor in aged ovariectomized rats. Bone 31:143\u2013148","journal-title":"Bone"},{"key":"1998_CR15","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/endo.136.8.7628403","volume":"136","author":"Dobnig","year":"1995","unstructured":"Dobnig H, Turner RT (1995) Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632\u20133638","journal-title":"Endocrinology"},{"key":"1998_CR16","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1172\/JCI119491","volume":"99","author":"Shizuya","year":"1997","unstructured":"Shizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A (1997) Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961\u20132970","journal-title":"J Clin Invest"},{"key":"1998_CR17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S8756-3282(00)00309-4","volume":"27","author":"Stanislaus","year":"2000","unstructured":"Stanislaus D, Yang X, Liang JD, Wolfe J, Cain RL, Onyia JE, Falla N, Marder P, Bidwell JP, Queener W, Hock JM (2000) In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1.34) fragment. Bone 27:209\u2013218","journal-title":"Bone"},{"key":"1998_CR18","first-page":"704","volume":"28","author":"Carroll","year":"2002","unstructured":"Carroll LA, Hanasono MM, Mikullec AA, Kita M, Koch RJ (2002) Triamcinolone stimulates bFGF production and inhibits TGF beta\u00a01 production by human derma fibroblast. Dermatol Surg 28:704\u2013709","journal-title":"Dermatol Surg"},{"key":"1998_CR19","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1681\/ASN.V12122787","volume":"12","author":"Ogata","year":"2001","unstructured":"Ogata S, Yorioka N, Kohno N (2001) Glucose and prednisolone alter basic fibroblast growth factor expression in peritoneal mesothelial cells and fibroblasts. J Am Soc Nephrol 12:2787\u20132796","journal-title":"J Am Soc Nephrol"},{"key":"1998_CR20","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/39.11.1255","volume":"39","author":"Nagashima","year":"2000","unstructured":"Nagashima M, Wauke K, Hirano D, Ishigami S, Aono H, Takai M, Sasano M, Yoshino S (2000) Effect of combinations of anti-rheumatic drugs on the production of vascular endothelial cell growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. Rheumatology 39:1255\u20131262","journal-title":"Rheumatology"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-005-1998-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-005-1998-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-005-1998-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:25:51Z","timestamp":1626395151000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-005-1998-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,19]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["1998"],"URL":"https:\/\/doi.org\/10.1007\/s00198-005-1998-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,19]]}}}